Interactions of levodopa
March 1, 2010 By
h3. Interactions of levodopa with other medicinal products and other forms of interaction Caution should be exercised when the following drugs are administered concomitantly with levodopa. Antihypertensive agents: Postural hypotension can occur when levodopa is use concomitantly with antihypertensive drugs. Dosage adjustment of the antihypertensive agent may be required. Antidepressants: Concomitant use of tricyclic antidepressants [...]
Seroquel XR prevents recurrence of BD
March 1, 2010 By
h3. Seroquel XR (quetiapine) Approved for Maintenance Treatment to Prevent Recurrence of Bipolar Disorder AstraZeneca announced that once-daily Seroquel XR (extended-release tablets) has been approved in Ireland for the prevention of recurrence of bipolar disorder (BD) in patients whose manic, mixed or depressive episode has responded to quetiapine treatment. Following this new indication, quetiapine is [...]
Cozatan
March 1, 2010 By
Company: Clonmel Healthcare Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Losartan (as K+ salt), 50mg, 100mg. Description: Round or oblong biconvex white film-coated tablets with breaking notch on both sides. 50mg tablet can be divided into equal quarters. 100mg tablet can be divided into equal halves. Presentation: 50mg-28, €9.54; 100mg-28, €16.03. Indications: Treatment [...]
Lecalpin
March 1, 2010 By
Company: Actavis Ireland Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Lercanidipine (HCl), 10mg, 20mg. Description: Resp. yellow or pink, round, biconvex, 6.5mm or 8.5mm film-coated tablets, scored on one side, marked L on the other. Presentation: 10mg-28, €8.22; 20mg-28, €13.42. Indication: Mild to moderate essential hypertension. Pharmacology: Lercanidipine is a calcium antagonist of [...]
Losartan Teva
March 1, 2010 By
Company: Teva Pharmaceuticals Ireland. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Losartan (K+) 50mg, 100mg. Description: White, oval, slightly arched film-coated tablets, debossed with strength on one side, scoreline on the other. Presentation: 50mg-28, €12.45; 100mg-28, €20.94. Indications: Treatment of essential hypertension. Treatment of renal disease in patients with hypertension and type 2 diabetes [...]
Lotanos
March 1, 2010 By
Company: Rowex Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Losartan K+ 50mg, 100mg. Description: 50mg: White oblong tablet with 1 notch on each side, embossed with 3 on one side. 100mg: White oblong tablet with 3 notches on both sides, embossed with 5 on one side. Presentation: 50mg-28, €11.73; 100mg-28, €19.71. Indications: Hypertension. [...]
Lotanos Comp
March 1, 2010 By
Company: Rowex Ltd. Legal category: Prescription. GMS. Sport prohibited. Active ingredients: Losartan K+/hydrochlorothiazide 50/12.5mg, 100/25mg. Description: Light yellow, round, biconvex film-coated tablets. Presentations: 50/12.5mg-28, €12.46; 100/25mg-28, €23.83. Indication: Essential hypertension in patients whose blood pressure is not adequately controlled on losartan or hydrochlorothiazide alone. Pharmacology: The components of Lotanos Comp have been shown to have [...]
Onbrez
March 1, 2010 By
Company: Novartis Ireland Ltd. Legal category: Prescription. GMS. Sport prohibited. Active ingredient: Indacaterol 150µg, 300µg. Description: Inhalation powder, in clear colourless hard capsules. Presentations: 150µg-30, €34.56; 300µg-30, €34.56. Indication: Maintenance bronchodilator treatment of airflow obstruction in adult patients with chronic obstructive pulmonary disease (COPD). Pharmacology: The pharmacological effects of beta2-adrenoceptor agonists are at least in [...]
Salbuvent
March 1, 2010 By
Company: Clonmel Healthcare Ltd. Legal category: Prescription. GMS. Sport-restricted β 2 agonists. Active ingredient: Salbutamol (sulphate) 2.5mg. Description: Clear, colourless to pale yellow nebuliser solution in a clear, plastic single dose ampoule. Presentation: 2.5 mg/2.5ml-20, €2.45; 5 mg/2.5ml-20, €6.07. Indications: Routine management of chronic bronchospasm unresponsive to conventional therapy. Treatment of acute severe asthma. Pharmacology: [...]
Loading ...
